The molecular genetic architecture of attention deficit hyperactivity disorder

Molecular Psychiatry

Volumn 20, Issue 3, 2015, Pages 289-297

  Hawi, Z ^a   Cummins, T D R ^a   Tong, J ^a   Johnson, B ^a   Lau, R ^a   Samarrai, W ^b   Bellgrove, M A ^a  

^a MONASH UNIVERSITY   (Australia)

^b NEW YORK CITY COLLEGE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; BIOINFORMATICS; CADHERIN 13 GENE; CASE CONTROL STUDY; COPY NUMBER VARIATION; DRD4 GENE; DRD5 GENE; ENDOPHENOTYPE; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GIT1 GENE; GLUCOSE FRUCTOSE OXIDOREDUCTASE DOMAIN 1 GENE; GLUTAMATE RECEPTOR 1 GENE; GLUTAMATE RECEPTOR 5 GENE; GLUTAMATE RECEPTOR 7 GENE; GLUTAMATE RECEPTOR 8 GENE; HTR1B GENE; HUMAN; LPHN3 GENE; MENTAL DISEASE; MOLECULAR GENETICS; NOS1 GENE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE TRAIT; REVIEW; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC6A3 GENE; SLC6A4 GENE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25 GENE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DNA COPY NUMBER VARIATIONS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS;

EID: 84924726491     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.183     Document Type: Review

References (103)

1. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993; 50: 565-576
2. Konstenius M, Larsson H, Lundholm L, Philips B, Glind GV, Jayaram-Lindström N, et al. An epidemiological studysubstance use, and comorbid problems in incarcerated women of ADHD, substance use, and comorbid problems in incarcerated women in Sweden. J Atten Disord 2012; 19: 44-52
3. Levy F, Hay DA, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997; 36: 737-744
4. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753
5. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-Avidity binding to beta-Amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977-1981
6. Maher B. Personal genomes: the case of the missing heritability. Nature 2008; 456: 18-21
7. El-Fishawy P, State MW. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr Clin North Am 2010; 33: 83-105
8. International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789-796
9. Kenny EM, Cormican P, Furlong S, Heron E, Kenny G, Fahey C, et al. Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol Psychiatry 2013; 19: 872-879
10. Lyon GJ, Jiang T, Van Wijk R, Wang W, Bodily PM, Xing J, et al. Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications. Discov Med 2011; 12: 41-55
11. Barry E, Hawi Z, Kirlet A. Avenues for pharmacogenetic research in ADHD. In: Fitzgerald M, Bellgrove M, Gill M (eds). A handbook of Attention Deficit Hyperactivity Disorder. John Wiley & Sons, Ltd, 2007, pp 357-358
12. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606-612
13. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999; 283: 397-401
14. Russell VA. The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique. Neurosci Biobehav Rev 2000; 24: 133-136
15. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001; 1: 152-156
16. Spencer TJ, Biederman J, Faraone S V, Madras BK, Bonab A, Dougherty DD, et al. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects. Biol Psychiatry 2013; 74: 84-89
17. Markant J, Cicchetti D, Hetzel S, Thomas KM. Relating dopaminergic and cholinergic polymorphisms to spatial attention in infancy. Dev Psychol 2014; 50: 360-369
18. Boonstra AM, Kooij JJS, Buitelaar JK, Oosterlaan J, Sergeant JA, Heister JGAM, et al. An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD. Am J Med Genet B Neuropsychiatr Genet 2008; 147: 397-402
19. Neale BM, Medland S, Ripke S, Anney RJL, Asherson P, Buitelaar J, et al. Casecontrol genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49: 906-920
20. Hinney A, Scherag A, Jarick I, Albayrak Ö, Pütter C, Pechlivanis S, et al. Genomewide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 888-897
21. Stergiakouli E, Hamshere M, Holmans P, Langley K, Zaharieva I, Hawi Z, et al. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry 2012; 169: 186-194
22. Yang L, Neale BM, Liu L, Lee SH, Wray NR, Ji N, et al. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 419-430
23. Mick E, Todorov A, Smalley S, Hu X, Loo S, Todd RD, et al. Family-based genomewide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49: 898-905.e3
24. Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Maller JB, et al. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1337-1344
25. Lasky-Su J, Neale BM, Franke B, Anney RJL, Zhou K, Maller JB, et al. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1345-1354
26. Lesch K-P, Timmesfeld N, Renner TJ, Halperin R, Röser C, Nguyen TT, et al. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 2008; 115: 1573-1585
27. Ebejer JL, Duffy DL, van der Werf J, Wright MJ, Montgomery G, Gillespie N, et al. Genome-wide association study of inattention and hyperactivity-impulsivity measured as quantitative traits. Twin Res Hum Genet 2013; 16: 560-574
28. Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch K-P, et al. Metaanalysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49: 884-897
29. Zhou K, Asherson P, Sham P, Franke B, Anney RJL, Buitelaar J, et al. Linkage to chromosome 1p36 for attention-deficit/hyperactivity disorder traits in school and home settings. Biol Psychiatry 2008; 64: 571-576
30. Takeuchi T, Misaki A, Liang SB, Tachibana A, Hayashi N, Sonobe H, et al. Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells. J Neurochem 2000; 74: 1489-1497
31. Valera EM, Faraone S V, Murray KE, Seidman LJ. Meta-Analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry 2007; 61: 1361-1369
32. Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet 2012; 44: 78-84
33. Reimand J, Arak T, Vilo J. g:Profiler-A web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res 2011; 39: W307-W315
34. Poelmans G, Pauls DL, Buitelaar JK, Franke B. Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. Am J Psychiatry 2011; 168: 365-377
35. Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med 2010; 61: 437-455
36. Cook EH, Scherer SW. Copy-number variations associated with neuropsychiatric conditions. Nature 2008; 455: 919-923
37. Elia J, Gai X, Xie HM, Perin JC, Geiger E, Glessner JT, et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 2010; 15: 637-646
38. Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, Fossdal R, et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010; 376: 1401-1408
39. Lionel AC, Crosbie J, Barbosa N, Goodale T, Thiruvahindrapuram B, Rickaby J, et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med 2011; 3: 95ra75
40. Williams NM, Franke B, Mick E, Anney RJL, Freitag CM, Gill M, et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry 2012; 169: 195-204
41. Jarick I, Volckmar AL, Pütter C, Pechlivanis S, Nguyen TT, Dauvermann MR, et al. Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder. Mol Psychiatry 2014; 19: 115-121
42. Lesch K-P, Selch S, Renner TJ, Jacob C, Nguyen TT, Hahn T, et al. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry 2011; 16: 491-503
43. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 2008; 40: 880-885
44. Demeter E, Sarter M. Leveraging the cortical cholinergic system to enhance attention. Neuropharmacology 2013; 64: 294-304
45. Cristino AS, Williams SM, Hawi Z, An J-Y, Bellgrove MA, Schwartz CE, et al. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol Psychiatry 2014; 19: 294-301
46. Stark C, Breitkreutz B-J, Chatr-Aryamontri A, Boucher L, Oughtred R, Livstone MS, et al. The BioGRID interaction database: 2011 update. Nucleic Acids Res 2011; 39: D698-D704
47. Mathivanan S, Ahmed M, Ahn NG, Alexandre H, Amanchy R, Andrews PC, et al. Human Proteinpedia enables sharing of human protein data. Nat Biotechnol 2008; 26: 164-167
48. Heinzen EL, Ge D, Cronin KD, Maia JM, Shianna K V, Gabriel WN, et al. Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol 2008; 6: e1
49. Tovo-Rodrigues L, Rohde LA, Roman T, Schmitz M, Polanczyk G, Zeni C, et al. Is there a role for rare variants in DRD4 gene in the susceptibility for ADHD? Searching for an effect of allelic heterogeneity. Mol Psychiatry 2012; 17: 520-526
50. Tovo-Rodrigues L, Rohde L, Menezes AMB, Polanczyk GV, Kieling C, Genro JP, et al. DRD4 rare variants in Attention-Deficit/Hyperactivity Disorder (ADHD): further evidence from a birth cohort study. PLoS One 2013; 8: e85164
51. Reiersen AM, Constantino JN, Volk HE, Todd RD. Autistic traits in a populationbased ADHD twin sample. J Child Psychol Psychiatry 2007; 48: 464-472
52. Ronald A, Simonoff E, Kuntsi J, Asherson P, Plomin R. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. J Child Psychol Psychiatry 2008; 49: 535-542
53. Greenwood TA, Joo E-J, Shekhtman T, Sadovnick AD, Remick RA, Keck PE, et al. Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 137-145
54. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008; 82: 477-488
55. Kirov G, Gumus D, Chen W, Norton N, Georgieva L, Sari M, et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 2008; 17: 458-465
56. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders : a genome-wide analysis. Lancet 2013; 381(9875): 1371-1379
57. O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D, et al. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 2011; 16: 286-292
58. Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH, et al. Allelic variation in gene expression is common in the human genome. Genome Res 2003; 13: 1855-1862
59. Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR, et al. Functional analysis of human promoter polymorphisms. Hum Mol Genet 2003; 12: 2249-2254
60. Johnson A D, Gong Y, Wang D, Langaee TY, Shin J, Cooper-Dehoff RM, et al. Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension. Clin Pharmacol Ther 2009; 85: 36-44
61. Visscher PM. Sizing up human height variation. Nat Genet 2008; 40: 489-490
62. Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, Holmans P, et al. Biological insights from 108 schizophrenia-Associated genetic loci. Nature 2014; 511: 421-427
63. Kryukov G V, Shpunt A, Stamatoyannopoulos JA, Sunyaev SR. Power of deep, all- exon resequencing for discovery of human trait genes. Proc Natl Acad Sci USA 2009; 106: 3871-3876
64. Kiezun A, Garimella K, Do R, Stitziel NO, Neale BM, McLaren PJ, et al. Exome sequencing and the genetic basis of complex traits. Nat Genet 2012; 44: 623-630
65. Almasy L, Blangero J. Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design. Am J Med Genet 2001; 105: 42-44
66. Castellanos FX, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002; 3: 617-628
67. Robinson MR, Wray NR, Visscher PM. Explaining additional genetic variation in complex traits. Trends Genet 2014; 30: 124-132
68. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636-645
69. Rasmussen ER, Neuman RJ, Heath AC, Levy F, Hay DA, Todd RD. Familial clustering of latent class and DSM-IV defined attention-deficit/hyperactivity disorder (ADHD) subtypes. J Child Psychol Psychiatry 2004; 45: 589-598
70. Wijsman EM, Amos CI. Genetic analysis of simulated oligogenic traits in nuclear and extended pedigrees: summary of GAW10 contributions. Genet Epidemiol 1997; 14: 719-735
71. Groen-Blokhuis MM, Middeldorp CM, Kan K-J, Abdellaoui A, van Beijsterveldt CEM, Ehli EA, et al. Attention-deficit/hyperactivity disorder polygenic risk scores predict attention problems in a population-based sample of children. J Am Acad Child Adolesc Psychiatry 2014; 53: 1123-9.e6
72. Waldman ID. Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1347-1356
73. Doyle AE, Willcutt EG, Seidman LJ, Biederman J, Chouinard V-A, Silva J, et al. Attention-deficit/hyperactivity disorder endophenotypes. Biol Psychiatry 2005; 57: 1324-1335
74. Kuntsi J, Stevenson J. Psychological mechanisms in hyperactivity: II. The role of genetic factors. J Child Psychol Psychiatry 2001; 42: 211-219
75. Andreou P, Neale BM, Chen W, Christiansen H, Gabriels I, Heise A, et al. Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects. Psychol Med 2007; 37: 1703-1715
76. Crosbie J, Schachar R. Deficient inhibition as a marker for familial ADHD. Am J Psychiatry 2001; 158: 1884-1890
77. Crosbie J, Arnold P, Paterson A, Swanson J, Dupuis A, Li X, et al. Response inhibition and ADHD traits: correlates and heritability in a community sample. J Abnorm Child Psychol 2013; 41: 497-507
78. McAuley T, Crosbie J, Charach A, Schachar R. The persistence of cognitive deficits in remitted and unremitted ADHD: a case for the state-independence of response inhibition. J Child Psychol Psychiatry 2014; 55: 292-300
79. Himpel S, Banaschewski T, Grüttner A, Becker A, Heise A, Uebel H, et al. Duration discrimination in the range of milliseconds and seconds in children with ADHD and their unaffected siblings. Psychol Med 2009; 39: 1745-1751
80. Nikolas MA, Nigg JT. Nikolas MA, Nigg JT. Moderators of neuropsychological mechanism in attention- deficit hyperactivity disorder. J Abnorm Child Psychol; e-pub ahead of print July 20 2014
81. Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CHD, Ramos-Quiroga J, et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry 2012; 17: 960-987
82. Tye C, Rijsdijk F, Greven CU, Kuntsi J, Asherson P, McLoughlin G. Shared genetic influences on ADHD symptoms and very low-frequency EEG activity: a twin study. J Child Psychol Psychiatry 2012; 53: 706-715
83. Fair DA, Posner J, Nagel BJ, Bathula D, Dias TGC, Mills KL, et al. Atypical default network connectivity in youth with attention-deficit/hyperactivity disorder. Biol Psychiatry 2010; 68: 1084-1091
84. Glahn DC, Winkler AM, Kochunov P, Almasy L, Duggirala R, Carless MA, et al. Genetic control over the resting brain. Proc Natl Acad Sci USA 2010; 107: 1223-1228
85. Bellgrove MA, Hawi Z, Kirley A, Gill M, Robertson IH. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: Sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Neuropsychologia 2005; 43: 1847-1857
86. Johnson KA, Kelly SP, Robertson IH, Barry E, Mulligan A, Daly M, et al. Absence of the 7-repeat variant of the DRD4 VNTR is associated with drifting sustained attention in children with ADHD but not in controls. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 927-937
87. Kollins SH, Anastopoulos AD, Lachiewicz AM, FitzGerald D, Morrissey-Kane E, Garrett ME, et al. SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1580-1588
88. Frazier-Wood AC, Bralten J, Arias-Vasquez A, Luman M, Ooterlaan J, Sergeant J, et al. Neuropsychological intra-individual variability explains unique genetic variance of ADHD and shows suggestive linkage to chromosomes 12, 13, and 17. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 131-140
89. Cummins TDR, Jacoby O, Hawi Z, Nandam LS, Byrne MA V, Kim B-N, et al. Alpha-2A adrenergic receptor gene variants are associated with increased intraindividual variability in response time. Mol Psychiatry 2013; 19: 1031-1036
90. Fair DA, Bathula D, Nikolas MA, Nigg JT. Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD. Proc Natl Acad Sci USA 2012; 109: 6769-6774
91. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993-998
92. Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a metaanalytic review. Hum Genet 2009; 126: 51-90
93. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1: 121-124
94. Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999; 4: 192-196
95. Manor I, Tyano S, Mel E, Eisenberg J, Bachner-Melman R, Kotler M, et al. Family- based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 2002; 7: 626-632
96. Hawi Z, Dring M, Kirley A, Foley D, Kent L, Craddock N, et al. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multicentre sample. Mol Psychiatry 2002; 7: 718-725
97. Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M. Synaptosomal-Associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol Psychiatry 2002; 7: 913-917
98. De Silva MG, Elliott K, Dahl H-H, Fitzpatrick E, Wilcox S, Delatycki M, et al. Disruption of a novel member of a sodium/hydrogen exchanger family and DOCK3 is associated with an attention deficit hyperactivity disorder-like phenotype. J Med Genet 2003; 40: 733-740
99. Arcos-Burgos M, Jain M, Acosta MT, Shively S, Stanescu H, Wallis D, et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry 2010; 15: 1053-1066
100. Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, Bosch R, Richarte V, Palomar G, et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes Brain Behav 2011; 10: 149-157
101. Won H, Mah W, Kim E, Kim J-W, Hahm E-K, Kim M-H, et al. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice. Nat Med 2011; 17: 566-572
102. Reif A, Jacob CP, Rujescu D, Herterich S, Lang S, Gutknecht L, et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 2009; 66: 41-50
103. Franke B, Neale BM, Faraone S V. Genome-wide association studies in ADHD. Hum Genet 2009; 126: 13-50